Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment
Department of Psychiatry
Antipsychotic Agents; Dextroamphetamine; Diphenhydramine; Fluoxetine; Humans; Male; Mental Disorders; Movement Disorders; Perphenazine; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Videotape Recording
Risk factors for neuroleptic withdrawal dyskinesia in children have not been well studied. The authors present a case of a child who had been treated with a combination of neuroleptics and stimulants for nonpsychotic aggressive behavior. A severe withdrawal dyskinesia precipitated by neuroleptic tapering was ameliorated by discontinuation of the psycho-stimulant. Although stimulants have been reported to increase certain involuntary movement disorders, this is the first known report of psychostimulant exacerbation of withdrawal dyskinesia.
DOI of Published Version
J Am Acad Child Adolesc Psychiatry. 1995 Nov;34(11):1490-4. Link to article on publisher's website
Journal of the American Academy of Child and Adolescent Psychiatry
Connor DF, Benjamin S, Ozbayrak KR. (1995). Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment. Psychiatry Publications and Presentations. https://doi.org/10.1097/00004583-199511000-00016. Retrieved from https://escholarship.umassmed.edu/psych_pp/457